NARA Discovery
NARA Subscribed Scholarly Literature Discovery
Boolean search: climate AND coral · microplastic OR nanoplastic · plastic NOT freshwater · "marine heatwave"
Advanced Search
Topic searches article titles and abstracts. Starts a new search; publisher and year refine it.
Searches article titles and abstracts.
Accepts bare DOI, doi: prefix, or a doi.org URL.
Complete publisher name. Publisher imprints are grouped under their main publisher where applicable.
Exact match by full journal title or ISSN.
–
Refine Results Clear Filters
Collection
NARA Subscribed2
Publisher
Springer Nature2
Journal
Acta Neurologica Belgica1
Naunyn-Schmiedeberg's Archives of Pharmacology1
Publication Year
20261
20251
Mark Messak results 2 · Newest (Page 1/1, per page 25)
Export CSV Export RIS Export current results · up to 5,000 records
Author: Mark Messak ×Clear All Filters
Search Results
Therapeutic effects of cannabinoids on Parkinson’s disease: an updated systematic review and meta-analysis of randomized controlled trialsNARA Subscribed
Acta Neurologica Belgica · 2026 · Springer
Mark Messak; Ahmed Abdelmageed; Ahmed Noureldeen Abbas; Youssef Mandour; Ahmed Talkhan; Mahmoud Fadel Eltohami; Dua’a Kanaan; Fawaz K. Alfahmi; Habiba Tariq Saeed; Lara Hamzeh Hamzeh; Lamees Taman; Ahmed Negida
View Details View Full Text
Efficacy and safety of GLP-1 agonists in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trialsNARA Subscribed
Naunyn-Schmiedeberg's Archives of Pharmacology · 2025 · Vol. 398 · Issue 8 · Springer
Mark Messak; Ahmed Abdelmageed; Abdelrahman A. Senbel; Youssef A. Khattab; Youssef Mandour; Omar Shaker; Ahmed Hamed Rehan; Samir Oransa; Mohamed Nasr; Abdullah Emad Shabeeb; Ziyad Rezq; Fares Hossam; Moaz Elsayed Abouelmagd
Recent trends suggest exploring the repurposing of different drugs for Parkinson’s disease patients (PD). One of these drugs is Glucagon-like peptide-1 (GLP-1), a medication used to treat type 2 diabetes mellitus. This systematic review and meta-analysis aimed to evaluate the efficacy and safety of different forms of GLP-1 agonists on motor and non-motor functions of PD patients during ON-medication and OFF-medication states....
View Details View Full Text